Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy

Background: Tumor PD-L1 levels have predictive value in PD-1/PD-L1 checkpoint blockade therapies, yet biopsies can only provide baseline information. Whether PD-L1 expression on circulating tumor cells (CTCs) could serve as an alternative biomarker is of great interest. Design: We established an imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Chunyan, Jiang, Yubo, Li, Ping, Wang, Yuehua, Xue, Jian, Li, Nannan, Li, Da, Wang, Ruina, Dang, Yongjun, Hu, Zhiyuan, Yang, Yanlian, Xu, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993493/
https://www.ncbi.nlm.nih.gov/pubmed/29900038
http://dx.doi.org/10.1080/2162402X.2018.1438111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993493/
https://www.ncbi.nlm.nih.gov/pubmed/29900038
http://dx.doi.org/10.1080/2162402X.2018.1438111

Ejemplares similares